Talking Points

Episode 133: The COBRA-REDUCE Trial

Informações:

Sinopsis

Robert Byrne and C. Michael Gibson discuss a randomized trial of a thromboresistant Polyzene F-coated stent with 14-day DAPT in high-bleeding-risk patients.